United Kingdom


British think tank declares Canada's cannabis legalization a 'modest success' — but has suggestions for improvement

Canada’s federal legalization of cannabis is a success – at least, according to a British think tank.

Prominent UK drug policy think tank Transform, which has been observing Canadian cannabis reform efforts with great interest since the country legalized the drug for adult use in October 2018. The organization has now compiled a comprehensive report on Canadian legalization.

“Legal regulation in Canada is still a relatively new project, but an extremely important one,” reads the report’s executive summary. “With the eyes of the world watching, the legal market has seen modest successes and is providing a valuable case study for regulators seeking to reduce the harm caused by drugs and drug markets.”


UK increases access to cannabis-based medicines as import restrictions are changed

Import restrictions have been changed to help ensure people with prescriptions for cannabis-based products for medicinal use do not have their treatment delayed or interrupted.

The changes will help patients with conditions such as rare, serious forms of epilepsy or multiple sclerosis.

Most cannabis-based medicines are imported from foreign countries. Export restrictions mean it can take weeks or months for the drugs to reach the patients in the UK. For example, in Canada, an export certificate can take 4 to 8 weeks.


Canadian company Sundial to grow U.K. CBD after buying supermarket supplier

Following a C$250 million boost, Canadian firm Sundial Growers has splashed out one of the U.K’s largest horticultural operations to supply the booming European CBD market.


UK food safety company partners cannabis producer

The Glasgow-based company produces test kits that test foodstuffs such as milk, spices, cereals and animal feed for toxins, including mycotoxins, microorganisms and GMOs. Recently developed methods have been applied to plant products such as herbal medicines, which have structural similarities to cannabis.

Claire Milligan, product manager at R-Biopharm Rhône, said: "Just like any other ingestible item, strict consumer protection legislation requires that cannabis products, including oils, cookies and cannabis plants themselves, should be tested for the presence of dangerous toxins.


U.K. legalizing cannabis supported by near-majority of voters

Almost half of Britons support the legalization of cannabis, according to a survey commissioned by a group associated with the ruling Conservative Party.


Tilray imports medical cannabis oil in bulk to UK

Tilray has managed to successfully import its first bulk supply of medical cannabis oil into the UK.


Canadian cannabis companies tapping U.K.'s deep-pocketed family offices for investment

Over the past three years, while Canadian licensed producers were raising millions in investor dollars from boutique investment firms on Bay Street, Scott Boyes embarked on a different route in the hunt for capital, one that led him to family offices and high net worth investors parked in the U.K.

“Bay Street — the Canaccords and Echelons and GMPs — were funding Canadian licensed producers that weren’t going to have any revenue or earnings for years. My U.K. partners said, ‘Look, we’ll get this funded, just come over to London,’” said Boyes, the chief executive of MPX International, which has cannabis cultivation and retail assets in Europe and South Africa and is listed on the CSE.


Tilray imports medical cannabis to U.K. after barriers are lifted

Tilray Inc. (TLRY.O) has imported its first bulk supply of medical cannabis oil into the U.K., after controversy over the confiscation of one of the Canadian company’s products led to an easing of restrictions.

The oral solution, containing both the psychoactive THC and non-intoxicating CBD compounds, is used to treat pain, chemotherapy-induced nausea and vomiting and multiple sclerosis-associated spasticity. It has already been supplied in bulk to Germany, Croatia, Cyprus and Malta.


Aurora Cannabis ships first commercial export to U.K. under new rules

Aurora Cannabis Inc. reports it has completed its first commercial export of cannabis oil to the United Kingdom and the product has been successfully dispensed from a pharmacy. “Authorities there recently granted the company approval for its first shipment of medical cannabis into the U.K. from Canada under its new legal framework that came into effect on Nov. 1, 2018,” notes a press release from Edmonton-headquartered Aurora, which has a funded capacity in excess of 500,000 kg a year and sales and operations in 22 countries across five continents.


Subscribe to RSS - United Kingdom